T2 Biosystems Sep 29, 2022 BARDA Provides Additional $3.7M to T2 Biosystems Under Contract Option Aug 30, 2022 T2 Biosystems Regains Nasdaq Listing Requirements Jul 15, 2022 In Brief This Week: Centogene, T2 Biosystems, Labcorp, More Jul 6, 2022 T2 Biosystems Reports Preliminary Drop in Q2 Revenues, Cuts Workforce Jun 10, 2022 In Brief This Week: Thermo Fisher Scientific, T2 Biosystems, MeMed, More May 27, 2022 In Brief This Week: Quidel, Ortho Clinical Diagnostics, T2 Biosystems, Agilent Technologies, More May 5, 2022 T2 Bio Q1 Revenues Inch up 3 Percent; Firm Warned by Nasdaq of Listing Non-Compliance Apr 6, 2022 Cytovale Prepping Sepsis Test for FDA Submission, Developing Index for COVID-19 Risk Stratification Premium Apr 1, 2022 T2 Biosystems Exercises BARDA Contract Option Valued at $4.4M Feb 18, 2022 T2 Biosystems Q4 Revenues Down 10 Percent, Beat Wall Street Expectations Jan 11, 2022 Danaher, PerkinElmer, Cue Health, Others Announce Preliminary Q4 Earnings Results Dec 27, 2021 Against Pandemic Backdrop, Sepsis Test Developers Accelerated Commercial Plans in 2021 Premium Nov 19, 2021 In Brief This Week: PerkinElmer, Labcorp, Illumina, Thermo Fisher Scientific, and More Nov 4, 2021 T2 Biosystems Q3 Revenues Jump 42 Percent Aug 5, 2021 T2 Biosystems Q2 Revenues More Than Double, Beat Estimates Jun 17, 2021 Cytovale Aiming to Enter Sepsis Testing Market With Rapid, Direct-From-Blood, Point-of-Care Platform Premium May 7, 2021 T2 Biosystems Advancing Pipeline, Accelerating Instrument Placement Strategy Premium May 6, 2021 T2 Biosystems Q1 Revenues Nearly Triple Mar 4, 2021 T2 Biosystems Q4 Revenues Jump 152 Percent on Strong Product Sales Jan 27, 2021 T2 Biosystems Preliminary Q4 Revenues Grow 155 Percent, Miss Estimates Load More Breaking News In Brief This Week: NIH, Thermo Fisher Scientific, Biocept, Castle Biosciences, Biodesix Biological Dynamics Taps Two Firms to Study Utility, Economics of Pancreatic Cancer Detection Test FDA Grants EUAs to Lucira Health Molecular COVID/Flu Test, Azure Biotech, CorDx COVID Antigen Tests Biocare Medical Acquires Empire Genomics Meridian Bioscience Fiscal Q4 Revenues Fall 14 Percent, Full-Year Revenues Grow 5 Percent Japanese Consortium Launches Study to Evaluate Utility of Blood-Based Alzheimer's Markers
